| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 3724572
[patent_doc_number] => 05700665
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-12-23
[patent_title] => 'Method for the extraction of periplasmic proteins from prokaryotic microorganisms in the presence of arginine'
[patent_app_type] => 1
[patent_app_number] => 8/594469
[patent_app_country] => US
[patent_app_date] => 1996-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6972
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/700/05700665.pdf
[firstpage_image] =>[orig_patent_app_number] => 594469
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/594469 | Method for the extraction of periplasmic proteins from prokaryotic microorganisms in the presence of arginine | Jan 30, 1996 | Issued |
Array
(
[id] => 4372398
[patent_doc_number] => 06303113
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-10-16
[patent_title] => 'Process for the production of pharmaceutical preparations containing human protein for infusion or injection purposes'
[patent_app_type] => 1
[patent_app_number] => 8/593579
[patent_app_country] => US
[patent_app_date] => 1996-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7940
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/303/06303113.pdf
[firstpage_image] =>[orig_patent_app_number] => 593579
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/593579 | Process for the production of pharmaceutical preparations containing human protein for infusion or injection purposes | Jan 29, 1996 | Issued |
Array
(
[id] => 3871635
[patent_doc_number] => 05824484
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-10-20
[patent_title] => 'RXR homodimer formation'
[patent_app_type] => 1
[patent_app_number] => 8/589528
[patent_app_country] => US
[patent_app_date] => 1996-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 17
[patent_no_of_words] => 9951
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/824/05824484.pdf
[firstpage_image] =>[orig_patent_app_number] => 589528
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/589528 | RXR homodimer formation | Jan 21, 1996 | Issued |
Array
(
[id] => 4154648
[patent_doc_number] => 06156535
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-12-05
[patent_title] => 'Mammalian IAP gene family, primers, probes, and detection methods'
[patent_app_type] => 1
[patent_app_number] => 8/576956
[patent_app_country] => US
[patent_app_date] => 1995-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 53
[patent_figures_cnt] => 24
[patent_no_of_words] => 26470
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/156/06156535.pdf
[firstpage_image] =>[orig_patent_app_number] => 576956
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/576956 | Mammalian IAP gene family, primers, probes, and detection methods | Dec 21, 1995 | Issued |
Array
(
[id] => 3780571
[patent_doc_number] => 05821057
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-10-13
[patent_title] => 'Assay for agents that affect cholesterol 7alpha-hydroxylase expression and a characterization of its regulatory elements'
[patent_app_type] => 1
[patent_app_number] => 8/562985
[patent_app_country] => US
[patent_app_date] => 1995-11-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 12
[patent_no_of_words] => 6281
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/821/05821057.pdf
[firstpage_image] =>[orig_patent_app_number] => 562985
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/562985 | Assay for agents that affect cholesterol 7alpha-hydroxylase expression and a characterization of its regulatory elements | Nov 26, 1995 | Issued |
Array
(
[id] => 3784679
[patent_doc_number] => 05840529
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-11-24
[patent_title] => 'Mammalian pro-hormone convertase'
[patent_app_type] => 1
[patent_app_number] => 8/545562
[patent_app_country] => US
[patent_app_date] => 1995-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 13
[patent_no_of_words] => 6600
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/840/05840529.pdf
[firstpage_image] =>[orig_patent_app_number] => 545562
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/545562 | Mammalian pro-hormone convertase | Oct 18, 1995 | Issued |
Array
(
[id] => 3770313
[patent_doc_number] => 05807680
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-09-15
[patent_title] => 'Method for simulataneous identification of differentially expresed mRNAS and measurement of relative concentrations'
[patent_app_type] => 1
[patent_app_number] => 8/544577
[patent_app_country] => US
[patent_app_date] => 1995-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 11361
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 96
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/807/05807680.pdf
[firstpage_image] =>[orig_patent_app_number] => 544577
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/544577 | Method for simulataneous identification of differentially expresed mRNAS and measurement of relative concentrations | Oct 16, 1995 | Issued |
| 08/517015 | MAMMALIAN PRO-HORMONE CONVERTASE | Aug 17, 1995 | Abandoned |
| 08/512946 | INHIBITORS OF APOPTOSIS | Aug 7, 1995 | Abandoned |
Array
(
[id] => 3655646
[patent_doc_number] => 05622856
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-04-22
[patent_title] => 'High efficiency helper system for AAV vector production'
[patent_app_type] => 1
[patent_app_number] => 8/510790
[patent_app_country] => US
[patent_app_date] => 1995-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 4
[patent_no_of_words] => 13269
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/622/05622856.pdf
[firstpage_image] =>[orig_patent_app_number] => 510790
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/510790 | High efficiency helper system for AAV vector production | Aug 2, 1995 | Issued |
| 08/510347 | MAMMALIAN PRO-HORMONE CONVERTASE | Aug 1, 1995 | Abandoned |
Array
(
[id] => 3884784
[patent_doc_number] => 05723333
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-03-03
[patent_title] => 'Human pancreatic cell lines: developments and uses'
[patent_app_type] => 1
[patent_app_number] => 8/509121
[patent_app_country] => US
[patent_app_date] => 1995-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 11
[patent_no_of_words] => 16483
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/723/05723333.pdf
[firstpage_image] =>[orig_patent_app_number] => 509121
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/509121 | Human pancreatic cell lines: developments and uses | Jul 30, 1995 | Issued |
Array
(
[id] => 4205799
[patent_doc_number] => 06027920
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-02-22
[patent_title] => 'System for protein expression and secretion especially in corynebacteria'
[patent_app_type] => 1
[patent_app_number] => 8/508761
[patent_app_country] => US
[patent_app_date] => 1995-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 32
[patent_no_of_words] => 28514
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/027/06027920.pdf
[firstpage_image] =>[orig_patent_app_number] => 508761
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/508761 | System for protein expression and secretion especially in corynebacteria | Jul 30, 1995 | Issued |
Array
(
[id] => 3986618
[patent_doc_number] => 05910438
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-06-08
[patent_title] => 'Cloning and/or sequencing vector'
[patent_app_type] => 1
[patent_app_number] => 8/379614
[patent_app_country] => US
[patent_app_date] => 1995-07-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 5424
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/910/05910438.pdf
[firstpage_image] =>[orig_patent_app_number] => 379614
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/379614 | Cloning and/or sequencing vector | Jul 19, 1995 | Issued |
Array
(
[id] => 3884265
[patent_doc_number] => 05723300
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-03-03
[patent_title] => 'Nuclear localized transcription factor kinase and diagnostic assays related thereto'
[patent_app_type] => 1
[patent_app_number] => 8/503062
[patent_app_country] => US
[patent_app_date] => 1995-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 14
[patent_no_of_words] => 16783
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/723/05723300.pdf
[firstpage_image] =>[orig_patent_app_number] => 503062
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/503062 | Nuclear localized transcription factor kinase and diagnostic assays related thereto | Jul 9, 1995 | Issued |
Array
(
[id] => 4038398
[patent_doc_number] => 05856461
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-01-05
[patent_title] => 'Oligonucleotides to inhibit the expression of isoprenyl protein transferases'
[patent_app_type] => 1
[patent_app_number] => 8/494301
[patent_app_country] => US
[patent_app_date] => 1995-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4545
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/856/05856461.pdf
[firstpage_image] =>[orig_patent_app_number] => 494301
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/494301 | Oligonucleotides to inhibit the expression of isoprenyl protein transferases | Jun 22, 1995 | Issued |
Array
(
[id] => 3734244
[patent_doc_number] => 05698442
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-12-16
[patent_title] => 'DNA encoding an 18 Kd CDK6 inhibiting protein'
[patent_app_type] => 1
[patent_app_number] => 8/476070
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7127
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/698/05698442.pdf
[firstpage_image] =>[orig_patent_app_number] => 476070
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/476070 | DNA encoding an 18 Kd CDK6 inhibiting protein | Jun 6, 1995 | Issued |
| 08/478457 | RETROVIRUS VECTORS FOR EXPRESSION OF CII-TA AND ACTIVATION OF HLA CLASS II GENE EXPRESSION AND USES THEREOF | Jun 6, 1995 | Abandoned |
Array
(
[id] => 3754680
[patent_doc_number] => 05851529
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-12-22
[patent_title] => 'Recombinant retroviruses'
[patent_app_type] => 1
[patent_app_number] => 8/477890
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 31
[patent_no_of_words] => 24640
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/851/05851529.pdf
[firstpage_image] =>[orig_patent_app_number] => 477890
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/477890 | Recombinant retroviruses | Jun 6, 1995 | Issued |
Array
(
[id] => 4034002
[patent_doc_number] => 05856185
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-01-05
[patent_title] => 'Method for making reflection defective retroviral vectors for infecting human cells'
[patent_app_type] => 1
[patent_app_number] => 8/472109
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 44
[patent_figures_cnt] => 54
[patent_no_of_words] => 36987
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/856/05856185.pdf
[firstpage_image] =>[orig_patent_app_number] => 472109
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/472109 | Method for making reflection defective retroviral vectors for infecting human cells | Jun 6, 1995 | Issued |